X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Thermo Fisher New HMW Kit Powers Long Read DNA Sequencing

    Thermo Fisher New HMW Kit Powers Long-Read DNA Sequencing

    Taiwan Grants Full Approval for NEFECON IgAN Treatment

    Taiwan Grants Full Approval for NEFECON IgAN Treatment

    Agentic AI in Pharma Transforming RD to Commercialisation

    Agentic AI in Pharma: Transforming R&D to Commercialisation

    New Software to Predict Cell Activity for Cancer Research

    New Software to Predict Cell Activity for Cancer Research

    Biosimulation Market Size

    Biosimulation Market Size and Growth Projections: 2025–2030

    The Future of Clinical

    The Future of Clinical Trial Data in Decentralisation Models

    GSK and Hengrui Pharma

    GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

    Aptar Pharma Bolsters Clinical Trial.

    Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Thermo Fisher New HMW Kit Powers Long Read DNA Sequencing

    Thermo Fisher New HMW Kit Powers Long-Read DNA Sequencing

    Taiwan Grants Full Approval for NEFECON IgAN Treatment

    Taiwan Grants Full Approval for NEFECON IgAN Treatment

    Agentic AI in Pharma Transforming RD to Commercialisation

    Agentic AI in Pharma: Transforming R&D to Commercialisation

    New Software to Predict Cell Activity for Cancer Research

    New Software to Predict Cell Activity for Cancer Research

    Biosimulation Market Size

    Biosimulation Market Size and Growth Projections: 2025–2030

    The Future of Clinical

    The Future of Clinical Trial Data in Decentralisation Models

    GSK and Hengrui Pharma

    GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

    Aptar Pharma Bolsters Clinical Trial.

    Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Thermo Fisher New HMW Kit Powers Long-Read DNA Sequencing

API PA by API PA
8th August 2025
in Manufacturing, News, Research & Development
Thermo Fisher New HMW Kit Powers Long Read DNA Sequencing

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Thermo Fisher Scientific has unveiled the Applied Biosystems MagMAX HMW DNA Kit, a new solution that supports both manual and automated workflows to enable extraction of High Molecular Weight (HMW) DNA, tailored for use in long-read DNA sequencing.

Developed for efficiency and consistency, the kit makes it easier to isolate large, intact, high-integrity DNA fragments from a wide range of sample types. With this, the laboratories can achieve dependable results while keeping processing time to a minimum.

As genomic applications continue to grow in sectors like biotech, pharmaceuticals, clinical research, and academic fields, the need for more efficient methods suited to long-read DNA sequencing has become evident. Until recently, scientists often had to rely on separate extraction kits depending on their sample type and process, which led to inconsistent results and delayed timelines due to the demands of manual preparation.

The MagMAX HMW DNA Kit responds to this challenge by offering a consistent method for obtaining high-quality HMW DNA. It produces fragments larger than 100 kilobases in under two hours and typically requires only 20 to 30 minutes of hands-on time. Being compatible with Thermo Scientific KingFisher Duo Prime, Flex, and Apex platforms, it allows labs to scale workflow easily while maintaining reproducibility. Its flexible design also includes a range of protocols, enabling labs to scale their operations as project demands shift.

“Researchers working with long-read sequencing face diverse sample types and throughput requirements but share the need for reliable, efficient DNA isolation. Our MagMAX HMW DNA Kit provides a streamlined, automated option that reduces bottlenecks and enables researchers to focus more on discovery,” said Kevin Lowitz, vice president and general manager, sample preparation at Thermo Fisher. 

“Our lab relies on long-read sequencing to study genomic structures and variations linked to human disease. The MagMAX HMW DNA Kit offers a simple, scalable solution that consistently produces high molecular weight DNA, ensuring we have trustworthy data for our research.,” said Alexis Tapanes-Castillo, PhD, associate professor of Biology, Lab Director, St. Thomas University.

Designed for speed and precision, the MagMAX HMW DNA Kit provides researchers with high-integrity DNA in less time, helping drive faster breakthroughs in oncology and genomics

Tags: Customised Solutions
Previous Post

Taiwan Grants Full Approval for NEFECON IgAN Treatment

Related Posts

Taiwan Grants Full Approval for NEFECON IgAN Treatment
Asia

Taiwan Grants Full Approval for NEFECON IgAN Treatment

7th August 2025
Agentic AI in Pharma Transforming RD to Commercialisation
Clinical Trials

Agentic AI in Pharma: Transforming R&D to Commercialisation

31st July 2025
New Software to Predict Cell Activity for Cancer Research
News

New Software to Predict Cell Activity for Cancer Research

30th July 2025
Biosimulation Market Size
Drug Development

Biosimulation Market Size and Growth Projections: 2025–2030

30th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In